42064 Federal Register / Vol. 63, No. 151 /Thursday, August 6, 1998 / Notices

of the district be redrawn to exclude

lands located within the Borough of

Chambersburg, based upon a claimed

loss of historic integrity of the area.

Documentation relative to the historic

integrity of this portion of the district

was submitted to the National Register.

Copies of this documentation are

available from the National Register at

the address below. In order to

accommodate those who wish to

provide new information concerning the

boundary of the Eastern Greene

Township Rural Historic District, the

National Park Service is providing a 60

day comment period. A written

statement on the determination of

eligibility will be issued by the National

Park Service within 30 days of the close

of the comment period.

The determination of eligibility

remains in effect pending review of

responses submitted during the

comment period. In order to revise the

boundary the National Park Service

must receive authoritative information,

which evaluated in conjunction with

documentation already on file, results in

a finding that the determined eligible

boundary does not accurately delineate

the historic district in accordance with

established National Register standards.

Comments should be addressed to the

National Register of Historic Places,

National Park Service, 1849 C St., N.W.,

Room NC400, Washington, D.C. 200240.

Carol D. Shull,

Keeper of the National Register of Historic

Places, National Register, History and

Education.

[FR Doc. 98–21015 Filed 8–5–98; 8:45 am]

BILLING CODE 4310–70–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importation of Controlled Substances;

Notice of Application

Pursuant to Section 1008 of the

Controlled Substances Import and

Export Act (21 U.S.C. 958(i)), the

Attorney General shall, prior to issuing

a registration under this Section to a

bulk manufacturer of a controlled

substance in Schedule I or II and prior

to issuing a regulation under Section

1002(a) authorizing the importation of

such a substance, provide

manufacturers holding registrations for

the bulk manufacture of the substance

an opportunity for a hearing.

Therefore, in accordance with Section

1301.34 of Title 21, Code of Federal

Regulations (CFR), notice is hereby

given that on May 1, 1998, applied

Science Labs, Inc., A Division of Altech

Associates, Inc., 2701 Carolean

Industrial Drive, P.O. Box 440, State

College, Pennsylvania 16801, made

application to the Drug Enforcement

Administration to be registered as an

importer of the basic classes of

controlled substances listed below:

Drug Schedule

Heroin (9200) ................................ I

Morphine (9300) ........................... II

The firm plans to import these

controlled substances for the

manufacture of reference standards.

Any manufacturer holding, or

applying for, registration as a bulk

manufacturer of these basic classes of

controlled substances may file written

comments on or objections to the

application described above and may, at

the same time, file a written request for

a hearing on such application in

accordance with 21 CFR 1301.43 in

such form as prescribed by 21 CFR

1316.47.

Any such comments, objections or

requests for a hearing may be addressed,

in quintuplicate, to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration, United States

Department of Justice, Washington, DC

20537, Attention: DEA Federal Register

Representative (CCR), and must be filed

no later than (30 days from publication).

This procedure is to be conducted

simultaneously with and independent

of the procedures described in 21 CFR

1301.34(b), (c), (d), (e), and (f). As noted

in a previous notice at 40 FR 43745–46

(September 23, 1975), all applicants for

registration to import the basic classes

of any controlled substances in

Schedule I or II are and will continue to

be required to demonstrate to the

Deputy Assistant Administrator, Office

of Diversion Control, Drug Enforcement

Administration that the requirements

for such registration pursuant to 21

U.S.C. 958(a), 21 U.S.C. 823(a), and 21

CFR 1301.34(a), (b), (c), (d), (e), and (f)

are satisfied.

Dated: July 17, 1998.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 98–20972 Filed 8–5–98; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importer of Controlled Substances;

Notice of Registration

By Notice dated April 17, 1998, and

published in the Federal Register on

April 30, 1998, (63 FR 23796), Johnson

Matthey, Inc., Custom Pharmaceuticals

Department, 2003 Nolte Drive, West

Deptford, New Jersey 08066, made

application to the Drug Enforcement

Administration (DEA) to be registered as

an importer of phenylacetone (8501), a

basic class of controlled substance listed

in Schedule II.

The phenylacetone will be imported

for conversion to amphetamine base,

isomers and salts thereof for sale in bulk

form to customers.

No comments or objections have been

received. DEA has considered the

factors in Title 21, United States Code,

Section 823(a) and determined that the

registration of Johnson Matthey, Inc. to

import phenylacetone is consistent with

the public interest and with United

States obligations under international

treaties, conventions, or protocols in

effect on May 1, 1971, at this time.

Therefore, pursuant to Section 1008(a)

of the Controlled Substances Import and

Export Act and in accordance with Title

21, Code of Federal Regulations, Section

1311.42, the above firm is granted

registration as an importer of the basic

classes of controlled substances listed

above.

Dated: July 17, 1998.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 98–20973 Filed 8–5–98; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated January 8, 1998, and

published in the Federal Register on

February 12, 1998 (63 FR 7182),

Nycomed, Inc., 33 Riverside Avenue,

Renssalaer, New York 12144 made

application to the Drug Enforcement

Administration (DEA) by letter to be

registered as a bulk manufacturer of

methylphenidate (1724).

A registered bulk manufacturer of

methylphenidate filed written

comments and an objection in response

to the notice of application. Review of

the APA’s definitions of license and